Change in cognitive functioning associated with ApoE genotype in a community sample of older adults

Psychology and Aging

Volumn 17, Issue 2, 2002, Pages 194-208

  Hofer, Scott M ^a   Christensen, Helen ^b   Mackinnon, Andrew J ^c,d   Korten, Ailsa E ^b   Jorm, Anthony F ^b   Henderson, Alexander S ^b   Easteal, Simon ^e  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^c FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e The Australian National University   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

AGED; AGING; ARTICLE; COGNITION; COMMUNITY; DEMENTIA; FEMALE; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HUMAN; MALE; MEMORY; NORMAL HUMAN; RESPONSE TIME; VERBAL BEHAVIOR; COGNITIVE DEFECT; GENETICS; MEMORY DISORDER; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; RISK FACTOR;

AGED; AGED, 80 AND OVER; AGING; APOLIPOPROTEINS E; COGNITION DISORDERS; DEMENTIA; FEMALE; GENOTYPE; HUMAN; MALE; MEMORY DISORDERS; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; HUMANS;

EID: 0036260556     PISSN: 08827974     EISSN: None     Source Type: Journal    
DOI: 10.1037/0882-7974.17.2.194     Document Type: Article

References (75)

1. Education, activity, health, blood pressure, and apolipoprotein E as predictors of cognitive change in old age: A review
2. Dementia: Age-dependent incidence, prevalence, and mortality in the old old
3. Comparative fit indexes in structural models
4. Significance tests and goodness of fit in the analysis of covariance structures
5. Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease
6. Patterns of brain activation in people at risk for Alzheimer's disease
7. Apolipoprotein E genotype in the prediction of cognitive decline and dementia in a prospectively studied elderly population
8. Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer's disease
9. Alternative ways of assessing model fit
10. The joint effect of apolipoprotein E ε4 and MRI findings on lower-extremity function and decline in cognitive function
11. Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins
12. Age is no kinder to the better educated: Absence of an association established using latent growth techniques in a community sample
13. Age differences and inter-individual variation in cognition in community dwelling elderly
14. Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease
15. Apolipoprotein E polymorphism and atherosclerosis
16. Informative dropout in longitudinal data analysis
17. APOE-ε4 is associated with memory decline in cognitively impaired elderly
18. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer's disease: A meta-analysis
19. Apolipoprotein e4 allele and cognitive decline in elderly men
20. Mini-"Mental State": A practical method for grading cognitive state of patients for the clinician
21. Maximizing the usefulness of data obtained with planned missing value patterns: An application of maximum likelihood procedures
22. Analysis with missing data in drug prevention research
23. Impaired olfaction as a marker for cognitive decline: Interaction with apolipoprotein E ε4 status
24. The role of APOE [ε]4 in modulating effects of other risk factors for cognitive decline in elderly persons
25. Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study
26. Apolipoprotein E allele ε4, dementia, and cognitive decline in a population sample
27. A survey of dementia in the Canberra population: Experience with ICD-10 and DSM-111-R criteria
28. Assessing personality structure using factorial invariance procedures
29. A robust five-factor structure of the 16PF: Evidence from independent rotation and confirmatory factorial invariance procedures
30. Understanding ageing: An evaluation of research designs for assessing the interdependence of ageing-related changes
31. Understanding ageing: Further commentary on the limitations of cross-sectional designs for ageing research
32. When is invariance not invariant: A practical scientist's look at the ethereal concept of factor invariance
33. Use it or lose it: Engaged lifestyle as a buffer of cognitive decline in aging?
34. Apolipoprotein E and cognitive change in an elderly population
35. Mortality risks in the elderly: Five-year follow-up of a total population
36. Prevalence and incidence of dementia in the oldest old: A longitudinal study of a population-based sample of 84-90-year-olds in Sweden
37. Early cognitive markers of the incidence of dementia and mortality: A longitudinal population-based study of the oldest old
38. Association between apolipoprotein E ε4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia
39. A multidimensional alternative to categorical diagnoses of dementia and depression in the elderly
40. APOE ε4 does not predict mortality, cognitive decline, or dementia in the oldest old
41. A prospective study of cognitive functioning in the elderly
42. Modeling the drop-out mechanism in repeated-measures studies
43. Dynamic but structural equation modeling of repeated measures data
44. An introduction to latent growth models for developmental data analysis
45. Latent growth curves within developmental structural equation models
46. Modeling incomplete longitudinal and cross-sectional data using latent growth structural models
47. Measurement invariance, factor analysis and factor invariance
48. The role of factorial invariance in modeling growth and change
49. Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype
50. The APOE ε4 allele is associated with decline on delayed recall performance in community-dwelling older adults
51. Cognitive function and apolipoprotein E in very old adults: Findings from the Nun Study
52. Inference with missing data
53. Longitudinal studies in aging research
54. The effect of pre-clinical dementia on estimates of normal cognitive function in aging
55. Apolipoprotein E genotype, atherosclerosis, and cognitive decline: The Rotterdam Study
56. Three-year changes in cognitive performance as a function of apolipoprotein E genotype: Evidence from very old adults without dementia
57. Apolipoprotein E4: An allele associated with many diseases
58. The Canberra Interview for the Elderly: A new field instruments for the diagnosis of dementia and depressed by ICD-10 and DSM-III-R
59. Apolipoprotein E genotypes and cognitive functions in healthy elderly persons
60. Apolipoprotein E phenotypes, dementia, and mortality in a prospective population sample
61. Heterogeneity's ruses: Some surprising effects of selection on population dynamics
62. Some results on reliability for the longitudinal measurement of change: Implications for the design of studies of individual growth
63. Using covariance structure analysis to detect correlations and predictors of individual change over time
64. Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women
65. Estrogen use, APOE, and cognitive decline: Evidence of gene- environment interaction